<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2277884-A4" country="EP" doc-number="2277884" kind="A4" date="20140101" family-id="41161537" file-reference-id="318266" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146553248" ucid="EP-2277884-A4"><document-id><country>EP</country><doc-number>2277884</doc-number><kind>A4</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-09731373-A" is-representative="YES"><document-id mxw-id="PAPP154827171" load-source="docdb" format="epo"><country>EP</country><doc-number>09731373</doc-number><kind>A</kind><date>20090409</date><lang>ZH</lang></document-id><document-id mxw-id="PAPP168014447" load-source="docdb" format="original"><country>EP</country><doc-number>09731373.8</doc-number><date>20090409</date><lang>ZH</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140447844" ucid="CN-200810052710-A" load-source="docdb"><document-id format="epo"><country>CN</country><doc-number>200810052710</doc-number><kind>A</kind><date>20080411</date></document-id></priority-claim><priority-claim mxw-id="PPC140453586" ucid="CN-2009000385-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>CN</country><doc-number>2009000385</doc-number><kind>W</kind><date>20090409</date></document-id></priority-claim><priority-claim mxw-id="PPC140445336" ucid="CN-200910131855-A" load-source="docdb"><document-id format="epo"><country>CN</country><doc-number>200910131855</doc-number><kind>A</kind><date>20090409</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988123088" load-source="docdb">A61P  35/00        20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988126250" load-source="docdb">C07H  15/252       20060101AFI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988131787" load-source="docdb">A61K  31/704       20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988134831" load-source="docdb">A61K  31/7042      20060101ALI20131120BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2073257775" load-source="docdb" scheme="CPC">C07H  19/044       20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073258433" load-source="docdb" scheme="CPC">C07H  15/252       20130101 FI20150417BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073263359" load-source="docdb" scheme="CPC">C07H  19/24        20130101 LI20150416BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132192228" lang="DE" load-source="docdb">ANTIBIOTISCHE ANTHRACYCLINDERIVATE MIT HOHER AKTIVITÄT, HERSTELLUNGSVERFAHREN UND ANWENDUNGEN DAVON</invention-title><invention-title mxw-id="PT132192229" lang="EN" load-source="docdb">ANTHRACYCLINE ANTIBIOTIC DERIVATIVES WITH HIGH ACTIVITY, PREPARATION METHODS AND USES THEREOF</invention-title><invention-title mxw-id="PT132192230" lang="FR" load-source="docdb">DÉRIVÉS ANTIBIOTIQUES D'ANTHRACYCLINE AYANT UNE ACTIVITÉ ÉLEVÉE, LEURS PROCÉDÉS DE FABRICATION ET LEURS UTILISATIONS</invention-title><citations><patent-citations><patcit mxw-id="PCIT377694187" load-source="docdb" ucid="GB-1589539-A"><document-id format="epo"><country>GB</country><doc-number>1589539</doc-number><kind>A</kind><date>19810513</date></document-id><sources><source name="SEA" category="XI" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT337292490" load-source="docdb" ucid="GB-2124224-A"><document-id format="epo"><country>GB</country><doc-number>2124224</doc-number><kind>A</kind><date>19840215</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT337292491" load-source="docdb" ucid="US-4202967-A"><document-id format="epo"><country>US</country><doc-number>4202967</doc-number><kind>A</kind><date>19800513</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT337292492" load-source="docdb" ucid="US-4314054-A"><document-id format="epo"><country>US</country><doc-number>4314054</doc-number><kind>A</kind><date>19820202</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT337292493" load-source="docdb" ucid="WO-1997019954-A1"><document-id format="epo"><country>WO</country><doc-number>1997019954</doc-number><kind>A1</kind><date>19970605</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit></patent-citations><non-patent-citations><nplcit><text>AJITO K ET AL: "Chemical modifications of antitumor anthracyclines for useful chemotherapeutics", TENNEN YUKI KAGOBUTSU TORONKAI KOEN YOSHISHU,, vol. 31, 1 January 1989 (1989-01-01), pages 452 - 458, XP009174307</text><sources><source mxw-id="PNPL58186901" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>ATTILA NAGY, ET AL.: "High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin,an analog 500-1000 times more potent: Structure-activity relationship of daunosamine-modified derivatives of doxorubicin", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 93, 1996, pages 2464 - 2469, XP002716610</text><sources><source mxw-id="PNPL58186902" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>LEWIS A D ET AL: "ROLE OF CYTOCHROME P-450 FROM THE HUMAN CYP3A GENE FAMILY IN THE POTENTIATION OF MORPHOLINO DOXORUBICIN BY HUMAN LIVER MICROSOMES", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 52, no. 16, 15 August 1992 (1992-08-15), pages 4379 - 4384, XP001182477, ISSN: 0008-5472</text><sources><source mxw-id="PNPL58186903" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>MIRGORODSKAYA O A ET AL: "Mass spectrometry method ERIAD in the structural study of anthracycline antibiotics", BIOORGANICHESKAYA KHIMIYA, IZDATEL'STVO NAUKA, RU, vol. 17, no. 4, 1 January 1991 (1991-01-01), pages 556 - 560, XP009174304, ISSN: 0132-3423</text><sources><source mxw-id="PNPL58186904" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>OLSUF'EVA E N ET AL: "Synthesis and mass spectrometry evaluation of N-cycloalkyl derivatives of carminomycin, daunorubicin and their analogs", BIOORGANICHESKAYA KHIMIYA, IZDATEL'STVO NAUKA, RU, vol. 16, no. 6, 1 January 1990 (1990-01-01), pages 847 - 853, XP009174303, ISSN: 0132-3423</text><sources><source mxw-id="PNPL58186905" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>PONOMAREVA L P ET AL: "A MODEL FOR ESTIMATING THE CHROMATOGRAPHIC MOBILITY OF ANTHRACYCLINE ANTIBIOTICS SUCH AS DAUNORUBICIN AND ITS SEMISYNTHETIC ANALOGS", KHIMIKO-FARMATSEVTICHESKII ZHURNAL, MOSCOW, RU, vol. 27, no. 8, 1 January 1993 (1993-01-01), pages 36 - 40, XP008027449, ISSN: 0023-1134</text><sources><source mxw-id="PNPL58186906" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>See also references of WO 2009124468A1</text><sources><source mxw-id="PNPL69879124" load-source="docdb" name="SEA"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR918156828" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>TIANJIN HEMAY BIO TECH CO LTD</last-name><address><country>CN</country></address></addressbook></applicant><applicant mxw-id="PPAR918150002" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>TIANJIN HEMAY BIO-TECH CO., LTD.</last-name></addressbook></applicant><applicant mxw-id="PPAR918139679" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>TIANJIN MICHELE SCI TECH DEV CO LTD</last-name><address><country>CN</country></address></addressbook></applicant><applicant mxw-id="PPAR918156515" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>TIANJIN MICHELE SCI-TECH DEVELOPMENT CO., LTD.</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918145084" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ZHANG HESHENG</last-name><address><country>CN</country></address></addressbook></inventor><inventor mxw-id="PPAR918164583" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ZHANG, HESHENG</last-name></addressbook></inventor></inventors></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS548972354" load-source="docdb">AT</country><country mxw-id="DS548827828" load-source="docdb">BE</country><country mxw-id="DS548981356" load-source="docdb">BG</country><country mxw-id="DS548857549" load-source="docdb">CH</country><country mxw-id="DS548968598" load-source="docdb">CY</country><country mxw-id="DS548972355" load-source="docdb">CZ</country><country mxw-id="DS548882406" load-source="docdb">DE</country><country mxw-id="DS548827829" load-source="docdb">DK</country><country mxw-id="DS548968599" load-source="docdb">EE</country><country mxw-id="DS548976073" load-source="docdb">ES</country><country mxw-id="DS548981357" load-source="docdb">FI</country><country mxw-id="DS548981362" load-source="docdb">FR</country><country mxw-id="DS548827830" load-source="docdb">GB</country><country mxw-id="DS548827831" load-source="docdb">GR</country><country mxw-id="DS548827832" load-source="docdb">HR</country><country mxw-id="DS548968600" load-source="docdb">HU</country><country mxw-id="DS548857550" load-source="docdb">IE</country><country mxw-id="DS548827833" load-source="docdb">IS</country><country mxw-id="DS548981363" load-source="docdb">IT</country><country mxw-id="DS548968601" load-source="docdb">LI</country><country mxw-id="DS548882407" load-source="docdb">LT</country><country mxw-id="DS548972356" load-source="docdb">LU</country><country mxw-id="DS548882408" load-source="docdb">LV</country><country mxw-id="DS548882409" load-source="docdb">MC</country><country mxw-id="DS548968800" load-source="docdb">MK</country><country mxw-id="DS548968801" load-source="docdb">MT</country><country mxw-id="DS548976074" load-source="docdb">NL</country><country mxw-id="DS548972357" load-source="docdb">NO</country><country mxw-id="DS548976075" load-source="docdb">PL</country><country mxw-id="DS548972362" load-source="docdb">PT</country><country mxw-id="DS548976076" load-source="docdb">RO</country><country mxw-id="DS548976077" load-source="docdb">SE</country><country mxw-id="DS548968602" load-source="docdb">SI</country><country mxw-id="DS548968806" load-source="docdb">SK</country><country mxw-id="DS548857551" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
